[ad_1]
The COVID-19 vaccine being developed by the University of Oxford and AstraZeneca has been shown to work as planned by new analysis.
A team from the University of Bristol developed a method to check that the inoculation contains all the correct parts, providing further evidence that the vaccine works.
Although the research has not yet been peer-reviewed, it has been hailed as a “wonderful example of interdisciplinary collaboration.”
The vaccine is currently in phase 3 clinical trials to further establish the safety of the treatment.
Comes after confirmation, testing will continue after a man participates died in brazil. It is understood that the man was taking a placebo and not the active vaccine.
The new analysis method allowed the scientists to verify that the vaccine was correctly designed to replicate the parts of the COVID-19 composition necessary to train the immune system to fight the disease.
The study demonstrated that the vaccine is correctly programmed to replicate the “spike protein” associated with COVID-19 that has been inserted into the immunization injection.
This protein is what the body’s immune system will learn to attack, providing people with the biological tools necessary to fight the virus.
Dr David Matthews, from Bristol College of Cellular and Molecular Medicine, who led the research, said: “This is an important study, as we can confirm that the genetic instructions behind this vaccine, which is being developed the most fast and safe as possible, they are followed correctly when they enter a human cell.
:: Subscribe to the daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker
“Until now, technology has not been able to provide answers as clearly, but now we know that the vaccine is doing everything we expected and that is just good news in our fight against the disease.
Sarah Gilbert, a professor of vaccinology at the University of Oxford and leader of the Oxford vaccine trial, added: “This is a wonderful example of interdisciplinary collaboration, using new technology to examine exactly what the vaccine does when it enters a cell. human.
“The study confirms that large amounts of coronavirus spike protein are produced with great precision, and this largely explains the success of the vaccine in inducing a strong immune response.”
